An In-Depth Overview of Interstitial Lung Diseases for Healthcare Professionals
OthersPage Navigation
Introduction
Interstitial Lung Diseases (ILDs) encompass over 200 pulmonary disorders, characterized by fibrotic and inflammatory changes in the lung interstitium.
Etiology and Classification
ILDs can be idiopathic, or related to systemic diseases, environmental exposure, or drugs. They're classified into four categories: idiopathic interstitial pneumonias, ILDs associated with systemic diseases, granulomatous ILDs, and other ILDs.
Clinical Presentation and Diagnosis
Patients typically present with dyspnea and dry cough. Diagnosis involves clinical evaluation, pulmonary function tests, high-resolution CT, and sometimes lung biopsy.
Treatment
Treatment varies depending on the specific ILD and its cause, but often involves corticosteroids and immunosuppressants.
Conclusion
Understanding ILDs is crucial for early detection and appropriate treatment, thereby improving patient outcomes.
Recommended News For You
Recommended Articles For You
Featured News
Featured Articles
Featured Events
Featured KOL Videos
1.
A Lot Can Be Said About You by Including Yourself in Photos.
2.
A new blood test greatly increases the ability to detect cancer.
3.
Novel biomarker has potential for predicting and treating skin cancer metastasis
4.
Anti-PD-L1 Plus Targeted Agent No Better Than Chemo for Resistant NSCLC
5.
No Survival Gain With Preoperative CRT Plus Perioperative Chemo for Gastric Cancer
1.
Preventing Heparin Induced Thrombocytopenia: Tips for Successful Anticoagulation Therapy
2.
Preventing Treatment-Related Secondary Malignancies: Evidence-Based Strategies for Clinical Practice
3.
Contemporary Frameworks in Oncology Across Clinical Settings
4.
What is Mullerian and How Does it Affect Your Health
5.
The Expanding Horizon of PSMA: A Comparative Clinical Review of Theranostics in Prostate Cancer and Beyond
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Understanding Common Causes of Abnormal Blood Counts
2.
Understanding Early Relapse in B-cell ALL: Rates, Risks, and Common Sites
3.
CDK4/6 Inhibitors Redefining Treatment for HR+/HER2- aBC In Post-Menopausal Women- A Panel Discussion
4.
Understanding Cancer: Early Detection and Treatment
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part IV
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Welcome to Hidoc Dr.
Join to enhance your clinical skills and gain specialized in-depth medical knowledge